United States · FDA National Drug Code directory
Bimatoprost
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60219-2149_34ba1345-2347-448c-8c94-b8b93404ade6
- Product NDC
- 60219-2149
- Form
- SOLUTION/ DROPS
- Composition / generic term
- Bimatoprost
- Labeler
- Amneal Pharmaceuticals NY LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250922
- Source listing expiry
- 20261231
Source-listed ingredients
- BIMATOPROST — .1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (60219-2149-1) / 2.5 mL in 1 BOTTLE · 60219-2149-1
- 1 BOTTLE in 1 CARTON (60219-2149-2) / 7.5 mL in 1 BOTTLE · 60219-2149-2
- 1 BOTTLE in 1 CARTON (60219-2149-4) / 5 mL in 1 BOTTLE · 60219-2149-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →